Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cumming, Georgia
- Most recent report
- 10-Q, filed Jan 10, 2025
- Incorporated
- Florida
- Filings on record
- 92 filings
- On EDGAR
- CIK 1468639
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 22
News 8 of 14
- 8-K Significant contract Dec 27, 2023
- 8-K Significant contract Jun 30, 2023
- 8-K Significant contract Jun 2, 2023
- 8-K/A Current report on a material event, amended May 18, 2023
- 8-K Current report on a material event May 17, 2023
- 8-K Leadership change Jan 12, 2023
- 8-K Leadership change Sep 28, 2022
- 8-K Leadership change Apr 12, 2022
Prospectuses and Registrations 5
- S-1 Registration statement for an offering Jun 30, 2023
- S-1/A Registration statement for an offering, amended Nov 20, 2009
- S-1/A Registration statement for an offering, amended Oct 27, 2009
- S-1/A Registration statement for an offering, amended Sep 29, 2009
- S-1 Registration statement for an offering Jul 17, 2009
Ownership 8 of 18
- SCHEDULE 13G Large holder reported a passive stake Mar 21, 2025
- 3 Insider reported their initial holding Mar 21, 2025
- 4 Insider reported a trade Sep 8, 2010
- 4 Insider reported a trade Aug 16, 2010
- SC 13G Large holder reported a passive stake May 20, 2010
- 3 Insider reported their initial holding May 20, 2010
- 4/A Insider reported a trade, amended Jan 29, 2010
- 4 Insider reported a trade Jan 25, 2010
Other 8 of 33
Everything here comes from Vicapsys Life Sciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.